Document is current
Any future updates will be listed below
-
Authors
Finze, Anika
Biechele, Gloria
Rauchmann, Boris-Stephan
Franzmeier, Nicolai https://orcid.org/0000-0001-9736-2283
Palleis, Carla
Katzdobler, Sabrina
Weidinger, Endy
Guersel, Selim https://orcid.org/0000-0001-6714-5827
Schuster, Sebastian
Harris, Stefanie
Schmitt, Julia
Beyer, Leonie
Gnörich, Johannes
Lindner, Simon
Albert, Nathalie L.
Wetzel, Christian H. https://orcid.org/0000-0002-5762-0003
Rupprecht, Rainer https://orcid.org/0000-0003-2939-9062
Rominger, Axel https://orcid.org/0000-0002-1954-736X
Danek, Adrian
Burow, Lena
Kurz, Carolin
Tato, Maia
Utecht, Julia
Papazov, Boris
Zaganjori, Mirlind
Trappmann, Lena-Katharina
Goldhardt, Oliver
Grimmer, Timo
Haeckert, Jan
Janowitz, Daniel
Buerger, Katharina
Keeser, Daniel https://orcid.org/0000-0002-0244-1024
Stoecklein, Sophia
Dietrich, Olaf https://orcid.org/0000-0001-6182-5039
Morenas-Rodriguez, Estrella
Barthel, Henryk
Sabri, Osama https://orcid.org/0000-0002-6425-3504
Bartenstein, Peter
Simons, Mikael
Haass, Christian
Höglinger, Günter U. https://orcid.org/0000-0001-7587-6187
Levin, Johannes
Perneczky, Robert https://orcid.org/0000-0003-1981-7435
Brendel, Matthias https://orcid.org/0000-0002-9247-2843
- License Information
-
More Information
Article History
Received: 22 November 2022
Revised: 27 June 2023
Accepted: 10 July 2023
First Online: 26 July 2023
Competing interests
: CH collaborates with Denali Therapeutics. CH is chief advisor of ISAR Bioscience and a member of the advisory board of AviadoBio. TG received consulting fees from AbbVie, Alector, Anavex, Biogen, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Noselab, Novo Nordisk, NuiCare, Orphanzyme, Roche Diagnostics, Roche Pharma, UCB, and Vivoryon; lecture fees from Grifols, Medical Tribune, Novo Nordisk, Roche Pharma, and Schwabe; and has received grants to his institution from Roche Diagnostics. GUH participated in industry-sponsored research projects from Abbvie, Biogen, Biohaven, Novartis, Roche, Sanofi, UCB; serves as a consultant for Abbvie, Alzprotect, Aprineua, Asceneuron, Bial, Biogen, Biohaven, Kyowa Kirin, Lundbeck, Novartis, Retrotope, Roche, Sanofi, UCB; received honoraria for scientific presentations from Abbvie, Bayer Vital, Bial, Biogen, Bristol Myers Squibb, Kyowa Kirin, Roche, Teva, UCB, Zambon; holds a patent on Treatment of Synucleinopathies. United States Patent No.: US 10,918,628 B2: EP 17 787 904.6-1109 / 3 525 788; received publication royalties from Academic Press, Kohlhammer, and Thieme. MB received speaker honoraria from GE healthcare, Roche and LMI and is an advisor of LMI. LB is a Novartis Radiopharmaceuticals GmbH employee since 10/2022, unrelated to this work.
